Avecho Biotechnology Ltd: Appendix 4D and Half-year Financial Report

Aug 25 21:22 ET · Announcements

Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial

MT NewswiresMay 15 21:42 ET

Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial

MT NewswiresMar 25 18:37 ET

Avecho to Push Forward With Phase III Trial of Anti-Insomnia Drug

MT NewswiresMar 14 07:41 ET

Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial

MT NewswiresMar 7 01:11 ET

Stocks of the Hour: Dotz Nano, Immuron, Avecho Biotechnology

sharecafeMar 6 19:43 ET